ArticleEClinicalMedicine2023

Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial.

Karolina Akinosoglou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.